Target intelligence / Profile preview

CCDC148 antisense RNA 1 (CCDC148-AS1)

Target
CCDC148-AS1
Molecular classification
Long non-coding RNA, Antisense RNA, Non-coding RNA
01

Overview

CCDC148 antisense RNA 1 (CCDC148-AS1) is a long non-coding RNA (lncRNA) located on chromosome 11 and is approximately 1,500 nucleotides in length[2]. It is classified as an antisense RNA, meaning it is complementary to the mRNA of the CCDC148 gene, and it does not encode a protein[2][3]. CCDC148-AS1 is expressed in several tissues, including the brain, heart, and liver, and interacts with RNA-binding proteins such as hnRNPK, suggesting a regulatory role[2]. Although its precise biological function remains largely uncharacterized, CCDC148-AS1 is implicated in the regulation of gene expression at the transcriptional, post-transcriptional, and possibly epigenetic levels, with roles suggested in controlling cell proliferation, apoptosis, and migration[2]. Like other antisense lncRNAs, it could potentially be involved in cancer-related pathways; however, specific disease associations or therapeutic targeting of CCDC148-AS1 have not been definitively established[4][2][3]. No drugs, biomarkers, or specific safety concerns related to CCDC148-AS1 are currently known.

Other names
CCDC148 antisense RNA 1 (non-protein coding)tmp_locus_26CCDC148-AS1
02

Biological functions

Regulation of gene expressionCell proliferationApoptosisCell migration
03

Disease associations

Cancer (based on the general role of antisense lncRNAs in cancer regulation; CCDC148-AS1 specifically has not been robustly implicated in disease according to current knowledge, but this is a potential)

Beyond the preview

Go deeper on CCDC148 antisense RNA 1 (CCDC148-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CCDC148 antisense RNA 1 (CCDC148-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call